Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | Mus musculus | Hanqiu Zheng | Apr 18, 2024 | ||||||
GSM7765986 |
CD45+ cells of Vector control overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7765987 |
CD45+ cells of wildtype Malt1 overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7765988 |
CD45+ cells of paracaspase-deficient Malt1 overexpression tumor
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770150 |
E0771 Vector control Rep1 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770151 |
E0771 Vector control Rep2 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770152 |
E0771 Malt1_WT_Rep1 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770153 |
E0771 Malt1_WT_Rep2 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770154 |
E0771 Malt1_PD_Rep1 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7770155 |
E0771 Malt1_PD_Rep2 after T cell killing
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774218 |
E0771, Vector control, Rep1
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774219 |
E0771, Vector control, Rep2
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774220 |
E0771, Vector control, Rep3
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774221 |
E0771, Malt1_WT, Rep1
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774222 |
E0771, Malt1_WT, Rep2
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774223 |
E0771, Malt1_WT, Rep3
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774224 |
E0771, Malt1_PD, Rep1
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774225 |
E0771, Malt1_PD, Rep2
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774226 |
E0771, Malt1_PD, Rep3
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774227 |
E0771, Malt1_V87R, Rep1
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 | ||||
GSM7774228 |
E0771, Malt1_V87R, Rep2
|
SRA | 1 | Hanqiu Zheng | Apr 18, 2024 |